2014 Symposium: Gene Patents After Myriad

Event Information

The North Carolina Journal of Law & Technology (“JOLT”) will host a symposium to discuss Association of Molecular Pathology v. Myriad Genetics, a 2013 United States Supreme Court case, and its ramifications for the future of gene science, and the practice of gene patenting in particular. In Myriad, the Supreme Court held that naturally occurring DNA sequences, even when isolated from the body, cannot be patented, but artificially created DNA is patent eligible because it is not naturally occurring.

The event will be held on Friday, February 21, 2014 from 8:00 a.m. to 1:00 p.m. in Chapel Hill at the Friday Center, which will provide breakfast and coffee, as well as lunch, for all participants. The Friday Center also provides free parking to all participants, but be sure to click here to print your free parking pass for the event.

Registration Information

To register, please fill out the JOLT Symposium Registration Form and email it to se.ncjolt@gmail.com by Thursday, February 13. Click here to pay your registration fee online.

Registration forms can also be mailed to the JOLT Office by the postmark deadline of Monday, February 10th. Please include a check for the registration fee in your mailing.

Attorneys who are licensed by the North Carolina State Bar and attend the Symposium may elect to receive 3.25 hours of CLE credit for attending the symposium.

Keynote Speaker and Panelists

Our keynote speaker will be Sandra Park, staff attorney with the ACLU Women’s Rights Project and co-counsel for the ACLU in the Myriad case.

Panelists will include:

Lori B. Andrews, Distinguished Professor of Law & Director of the Institute for Science Law and Technology at the Illinois Institute of Technology Chicago-Kent College of Law;

Christopher Holman, Professor of Law at the University of Missouri Kansas City School of Law;

Andrew Chin, Associate Professor of Law at the University of North Carolina School of Law;

Dr. Robert Cook-Deegan, Research Professor & Director, Genome Ethics, Law & Policy at Duke University;

Dr. James P. Evans, Bryson Distinguished Professor of Genetics and Medicine at the University of North Carolina;

John Conley, Kenan Professor of Law at the University of North Carolina School of Law